Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NeoGenomics Laboratories

Explore full profile

Cancer Reference laboratory

Fort Myers, United StatesFounded 2002Biotech & Life Sciences
Valuation $2.34B Market cap · Jul/2026
Revenue $804M Latest reported FY
EBITDA $57M Latest reported FY

At a glance

Status
Listed
Founded
2002
Headquarters
Fort Myers, United States
Listing
IPO 2013
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Talent

Book a demo to see the people
Employees mapped 1,804 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 11 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
10 countries with
team presence
🇺🇸 United States95.2%
🇬🇧 United Kingdom2.9%
🇮🇳 India1.1%
🇨🇭 Switzerland0.2%
🇷🇺 Russia0.1%
Top 5 of 10 shown
Web traffic by country
48K monthly visits
across markets
🇺🇸 United States84.2%
🇨🇦 Canada4.2%
🇬🇧 United Kingdom3.5%
🇮🇳 India3.1%
🇩🇪 Germany1.7%
Top 5 markets shown

Patents

Estimated portfolio value
$35M

43 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where NeoGenomics Laboratories was the backer or acquirer, 2014–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across NeoGenomics Laboratories's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where NeoGenomics Laboratories deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        NeoGenomics Laboratories's portfolio, mapped.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about NeoGenomics Laboratories on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See NeoGenomics Laboratories on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles